Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer

NCT06624878 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

568

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Cytoreductive Surgery
Depressive Symptom

Interventions

DRUG: esketamine
DRUG: placebo

Sponsor

Zhejiang Cancer Hospital